Skip to Content

Clinical Trials Search Results

Showing 1-10 of 34

Sorted By:

  • ACCRU RU011201I

    A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.

  • Alliance A011202

    A randomized phase iii trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy.

  • Alliance A031201

    Phrase III trial of Enzalutamide versus Enzalutamide, Abiraterone, and Prednisone for Castration Resistant Metastatic Prostate Cancer

  • Astex AT13397-05

    A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

  • BMS CA209-118

    Lung Cancer Molecular Profiling & Clinical Outcomes in U.S. Community Oncology Practices

  • BMS CA209-118

    Lung Cancer Molecular Profiling & Clinical Outcomes in U.S. Community Oncology Practices

  • CALGB 50904

    A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib, and Bendamustine in Patients with Untreated Follicular Lymphoma

  • CALGB 80702

    A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

  • Celgene ABI-007-NSCL-003

    A Phase III, randomized, open-label, cross-over, multi-center, safety and efficacy study to evaluate nab-paclitaxel (Abraxane) as maintenance treatment after induction with nab-paclitaxel plus carboplatin in subjects with squamous cell non-small cell lung cancer (NSCLC)

  • CTSU E1311

    A randomized, Placebo Controlled Phase II trial of Afatinib (BIBW2992) as Adjuvant Therapy following Chemoradiation in patients with Head and Neck squamous cell carcinoma at High risk of recurrence

Page of 4, showing trials 1-10 of 34

Also in this Section